Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 40.3B | 41.1B | 50.5B | 46.2B |
Cost of revenue | 35.7B | 35.8B | 43.8B | 37.4B |
Gross profit | 4.6B | 5.3B | 6.6B | 8.8B |
Operating expense | ||||
Research & development | 135M | 130M | 124M | 124M |
Selling general and admin | 1.7B | 1.6B | 1.3B | 1.3B |
Other operating expenses | — | — | — | — |
Operating income | 2.8B | 3.6B | 5.2B | 7.4B |
Non operating interest income | ||||
Income | 150M | 129M | 29M | 9M |
Expense | 481M | 477M | 287M | 519M |
Other income expense | -832M | -596M | -136M | -101M |
Pretax income | 1.6B | 2.6B | 4.8B | 6.8B |
Tax provision | 240M | 501M | 882M | 1.2B |
Net income | 1.4B | 2.1B | 3.9B | 5.6B |
Basic EPS | 4.2 | 6.5 | 11.8 | 16.8 |
Diluted EPS | 4.2 | 6.5 | 11.8 | 16.8 |
Basic average shares | 325M | 15.9M | 16.0M | 16.3M |
Diluted average shares | 325M | 15.9M | 16.0M | 16.3M |
EBITDA | 4.3B | 5.2B | 6.4B | 9.3B |
Net income from continuing op. | 1.4B | 2.1B | 3.9B | 5.6B |
Minority interests | -7M | -7M | -7M | -7M |
Preferred stock dividends | 7M | 7M | 10M | 14M |